TFS
MNTA

TrustCore Financial Services’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

TrustCore Financial Services’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-74
Closed -$2K – 1025
2018
Q2 		$2K Buy
+74
New +$1.59K ﹤0.01% 864

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TrustCore Financial Services's MNTA Position: Q3 2018 in Review

TrustCore Financial Services sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2018, closing a stake of 74 shares — an estimated $2K sold.

TrustCore Financial Services first reported a position in MNTA in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 159 funds tracked by Wall St. Rank hold MNTA as of Q3 2018.

  • TrustCore Financial Services reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • TrustCore Financial Services sold 74 Momenta Pharmaceuticals, Inc. shares in Q3 2018, an estimated $2K.
  • TrustCore Financial Services first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2018 and held it in 1 quarter.
  • TrustCore Financial Services's Momenta Pharmaceuticals, Inc. position peaked at $2K in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2018.

Based on TrustCore Financial Services's 13F filing for Q3 2018, filed 9 Nov 2018.